In patients with terminal renal failure, hypertension is the rule rather than the exception. Its pathogenesis can be attributed to salt and water retention in most patients, because removing fluid excess normalises their blood pressure (BP). Indeed regular ultrafiltration (UF) is an integral part of hemodialysis (HD) treatment and at least as important as removing toxic products.
Many patients gain so much weight (volume) between two HD sessions that the removal of that amount in the short time available for UF may cause complaints and an excessive BP decrease. In some patients, however, BP increases despite UF, even to frightening levels. For this unexpected increase I adopted the term "paradoxical". The first explanation which comes to mind is an "overshoot" of the counter-regulating mechanisms, in particular the reninangiotensin system, activated by the sudden decrease in volume. This explanation is usually accepted without much proof.
Unfortunately the role of the renin-angiotensin system in the maintenance and regulation of BP in HD patients has not been investigated systematically. Much information must be derived from older studies on rather small series of selected patients.
Initially it was estimated that 5-15% of HD patients have hypertension resistant to UF and thus caused by inappropriately high plasma renin activity (PRA). Nephrectomy often resulted in a dramatic drop in BP (1); and later similar successes were reported from treatment with converting enzyme inhibitors (CEI) (2) . In some patients however, BP can be normalised by UF despite high PRA (3), while it may decrease after bilateral nephrectomy in patients with normal PRA (4).
It has become apparent that non-functioning kidneys continue to secrete renin after many years of HD and can contribute to hypertension after transplantation. Thus the volume-renin scheme may be an oversimplification, and BP in some patients could depend on both renin and volume. No consensus exists on this point. While one author (3) stressed that good BP control can be achieved in most patients regardless of PRA levels, another (5) maintained that renin plays a major role in almost every case and that blocking this system "has a far more potent antihypertensive effect than does correction of volume expansion". Some of these contradictions may be explained by the fact that "reactivity" of PRA is very much decreased in patients with renal failure.
While PRA increases more than two-fold in normal subjects after acute decrease in volume or standing up (6) , this reaction is blunted or absent in many patients with renal failure (7) . However there are striking individual differences in this regard among HD patients. Increases in PRA after UF occur mainly, but not exclusively, in patients with high base-line PRA levels (8) .
Against this background it seems less likely but not impossible that PRA increases so much during UF as to cause paradoxical BP rises. Such a patient (who had malignant hypertension) was convincingly described by Brown et al (9) . In most of their patients however BP could be controlled by weight reduction despite widely varying renin levels, and renin even decreased during HD in most of them.
If renin were responsible for such crises it should be possible to treat or prevent them by CEI treatment. This was indeed reported in a preliminary study (10) . In six patients marked BP rises occured during HD or intermittent peritoneal dialysis, accompanied by a moderate increase in PRA in 4 of them. Administration of captopril before the sessions abolished these crises. However, because captogril was also effective in patients who had normal PRA which did not rise during UF, the authors conclude that "the action of captopril does not seem clearly secondary to the suppression of angiotensin II". It is not always easy to relate changes in BP to treatment interventions, particularly in HD patients. We have observed that BP in the same patient may vary remarkably from one dialysis session to the other and rises during UF may spontaneously subside.
A recent report (11) illustrates that many BP rises may be unrelated to renin. Eight patients with paradoxical rises were described which were in several cases not responsive to CEI treatment. All of them had cardiomegaly, sometimes with functional valvular insufficiency. After more vigorous, repeated UF their BP decreased, intradialytic rises subsided, and cardiac volumes and functions improved. Thus hypervolemia appears to be an important factor in this phenomenon. While explanations remain speculative at present, it should be remarked that HD itself, by increasing calcium levels, improves cardiac performance (12) .
Ultrafiltration-related hypertension
While UF often decreases blood volume and cardiac output, this may not happen if the heart is dilated. Indeed increases in ejection fraction and cardiac output were reported in some of these patients after a substantial weight loss, although such hemodynamic measurements could not be made at the very moment of the paradoxical increase. Thus while the exact mechanism has not yet been elucidated, it is clear that hypervolemia may set the stage for paradoxical increases and that these paroxysms subside when it is corrected.
It therefore is unfortunate that a recent textbook (13) states that "paradoxical hypovolemic hypertension may develop mediated by the renin-angiotensin system in response to a low circulating volume". This concept stems from the convinction that "dry weight" has been attained and that further UF will be harmful. Thus the search for further possible hypervolemia is discouraged. Hypertension aggravated by volume depletion has been exceptionally described in experimental malignant hypertension in
